Xingxing Qi
- Oncology top 10%
- Immunology
- Hepatology top 5%
- Molecular Biology
- Biomedical Engineering
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (3 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers)CAR-T cell therapy research (2 papers)
- Cited by
- HepatologyOncologyImmunology
- Partner nations
- ChinaUnited States
In The Last Decade
Xingxing Qi
11 papers receiving 462 citations
Peers
Comparison fields: 5 of 52
- Oncology 259
- Immunology 165
- Hepatology 133
- Molecular Biology 111
- Biomedical Engineering 65
Countries citing papers authored by Xingxing Qi
This map shows the geographic impact of Xingxing Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingxing Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingxing Qi more than expected).
Fields of papers citing papers by Xingxing Qi
This network shows the impact of papers produced by Xingxing Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingxing Qi. The network helps show where Xingxing Qi may publish in the future.
Co-authorship network of co-authors of Xingxing Qi
This figure shows the co-authorship network connecting the top 25 collaborators of Xingxing Qi. A scholar is included among the top collaborators of Xingxing Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingxing Qi. Xingxing Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 254 | |
| 2 | 1 | |
| 3 | 16 | |
| 4 | 16 | |
| 5 | 4 | |
| 6 | 23 | |
| 7 | 73 | |
| 8 | 14 | |
| 9 | 28 | |
| 10 | 17 | |
| 11 | 20 |
About Xingxing Qi
Xingxing Qi is a scholar working on Hepatology, Cancer Research and Oncology, having authored 11 papers that have together received 466 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Hepatology (133 citations), Oncology (259 citations) and Immunology (165 citations). Xingxing Qi has collaborated with scholars based in China and United States. Frequent co-authors include Bo Zhai, Jiachang Chi, Huamao Wang, Donghua Shi, Huiping Gao, Hua Jiang, Zonghai Li, Yao Shi, Ahmed O. Kaseb and Daijing Yuan. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.